COVID-19: all 7,775 studies

Page 59 of 78. Open to participants first (482), then studies with results posted, then the rest; newest registration first within each.

• RECHARGE: A Brief Psychological Intervention to Build Resilience in Healthcare Workers During COVID-19Status unknownNCT04531774Not applicable
• Selective Estrogen Modulation and Melatonin in Early COVID-19WithdrawnNCT04531748Phase 2
• Respiratory Syncytial Virus Infection May be More Dangerous in NeonateStatus unknownNCT04531735
• COVID-19 Saliva Test Research StudyCompletedNCT04531501
• Cytokine Status of Covid-19 PatientsCompletedNCT04531345
• Immune Cell Subgroups in Covid 19 PatientsCompletedNCT04531319
• Back to School COVID-19 Simulation StudyCompletedNCT04531254Not applicable
• CORE Study COVID-19Status unknownNCT04531202
• Glycemic Control Among Children and Adolescents With Type 1 Diabetes During COVID-19 Pandemic in EgyptStatus unknownNCT04531111
• COVID-19 in Rheumatic Inflammatory Diseases Under Immuno-suppressive DrugsCompletedNCT04530682
• Camostat and Artemisia Annua vs Placebo in COVID-19 OutpatientsTerminatedNCT04530617Phase 2
• Nebulized Heparin in Severe Acute Respiratory Syndrome COVID-19Status unknownNCT04530578Phase 4
• The Effect of Melatonin and Vitamin C on COVID-19CompletedNCT04530539Not applicable
• COVID-19 In-vitro Diagnostic Test and Androgen Receptor Gene ExpressionWithdrawnNCT04530500
• Outpatient Use of Ivermectin in COVID-19WithdrawnNCT04530474Phase 3
• PEP Flute-selfcare in COVID-19CompletedNCT04530435Not applicable
• Efficacy of Sofosbuvir Plus Ledipasvir in Egyptian Patients With COVID-19 Compared to Standard TreatmentCompletedNCT04530422Phase 3
• Timing of Corticosteroids in COVID-19, II. Post COVID-19 Follow-upActive, not recruitingNCT04530409Phase 4
• Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19Status unknownNCT04530396Phase 3
• Efficacy and Safety of Recovered Covid 19 Plasma Transfusion to Covid 19 Severly Ill PatientsStatus unknownNCT04530370Early Phase 1
• Reactogenicity, Safety and Immunogenicity of QazCovid-in® COVID-19 VaccineCompletedNCT04530357Phase 1/2
• Ivermectin to Prevent Hospitalizations in COVID-19CompletedNCT04529525Phase 2/3
• Healthy Volunteer COVID-19 Antibody Testing StudyWithdrawnNCT04529460
• Response of Korean Medicine Hospital to COVID-19CompletedNCT04529447
• Assocation Between In-person Instruction and COVID-19 RiskCompletedNCT04529421
• EARSATS-19: In-ear Measurement of Blood Oxygen Saturation in COVID-19 Follow upCompletedNCT04529408
• Evaluation of the Efficacy and Safety of Treatments for Patients Hospitalized for COVID-19 Infection Without Signs of Acute Respiratory Failure, in TunisiaWithdrawnNCT04528927Phase 3
• Study of seroPREvalence Vis-à-vis SARS-CoV2 and Correlation With Clinical Forms of COVID-19 in Patients Followed in Pneumology in the Cluster Area of the Grand-Est Region (Strasbourg University Hospital)Status unknownNCT04528901
• Steroids and Unfractionated Heparin in Critically Ill Patients With Pneumonia From COVID-19 InfectionStatus unknownNCT04528888Phase 3
• S-Nitrosylation Therapy of COVID-19WithdrawnNCT04528771Early Phase 1
• Study of the Safety and Efficacy of STI-5656 (Abivertinib Maleate) in Subjects Hospitalized Due to COVID-19CompletedNCT04528667Phase 2
• Convalescent Plasma for Treating Patients With COVID-19 Pneumonia Without Indication of Ventilatory SupportStatus unknownNCT04528368Phase 2
• Influence of Prior Infection With COVID-19 on Occurrence of Influenza-like Illness or Acute Respiratory InfectionCompletedNCT04527614Not applicable
• Extremely Premature Births During the Peak of the COVID-19 Pandemic: an International Study of the Active SafeBoosC III DepartmentsCompletedNCT04527601
• Study of the Safety, Reactogenicity and Immunogenicity of "EpiVacCorona" Vaccine for the Prevention of COVID-19CompletedNCT04527575Phase 1/2
• Colchicine in Moderate Symptomatic COVID-19 PatientsCompletedNCT04527562Not applicable
• Clinical Course and Treatment of COVID-19 Inpatients in HospitalCompletedNCT04527497
• Case Fatalities in Hospitalised COVID-19 Patients in the UKCompletedNCT04527458
• Pilot Study to Assess Efficacy and Safety of Treamid in the Rehabilitation of Patients After COVID-19 PneumoniaCompletedNCT04527354Phase 2
• Study to Evaluate the Efficacy and Safety of AstroStem-V in Treatment of COVID-19 PneumoniaStatus unknownNCT04527224Phase 1/2
• Effectiveness and Safety of Ivermectin for the Prevention of Covid-19 Infection in Colombian Health PersonnelStatus unknownNCT04527211Phase 3
• Brainstem Dysfunction in COVID-19 Critically Ill Patients: a Prospective Observational StudyCompletedNCT04527198Not applicable
• An Open Non-comparative Study of the Efficacy and Safety of Aprotinin in Patients Hospitalized With COVID-19Status unknownNCT04527133Not applicable
• Study of COVID-19 DNA Vaccine (AG0302-COVID19)CompletedNCT04527081Phase 1/2
• Phase III Trial of A COVID-19 Vaccine of Adenovirus Vector in Adults 18 Years Old and AboveCompletedNCT04526990Phase 3
• Differences in Immune Response Among HIV-1-infected Individuals With Previous or Current COVID-19 (CoVIHDis).Status unknownNCT04526977
• Detecting SARS-CoV-2 in TearsCompletedNCT04526769
• Heat Shock Protein Inhibitor- MPT0B640 for COVID-19 InfectionWithdrawnNCT04526717Phase 1
• Frequency of COVID-19 Antibodies in Patients With Hereditary Hematological DiseasesCompletedNCT04526405
• Morphological Abnormalities of the Olfactory Bulb on MRI and Olfactometry in Anosmic Versus Normosmic COVID-19 PatientsCompletedNCT04526054Not applicable
• Assessment of Long-term Impact Post COVID-19 for Patients and Health Care Professionals of the European HospitalStatus unknownNCT04525911
• High Dose Vitamin-D Substitution in Patients With COVID-19: a Randomized Controlled, Multi Center StudyCompletedNCT04525820Not applicable
• COVID-19 Pandemic and Parents of Disabled ChildrenCompletedNCT04525742Not applicable
• Endothelial Function and COVID-19CompletedNCT04525443
• Rapid Screening Test for Covid-19 Antibodies in Healthcare WorkersCompletedNCT04525417Not applicable
• MOIST Study: Multi-Organ Imaging With Serial Testing in COVID-19 Infected PatientsCompletedNCT04525404
• MSC-based Therapy in COVID-19-associated Acute Respiratory Distress SyndromeStatus unknownNCT04525378Phase 1
• Prediction Models for Diagnosis and Prognosis of Severe COVID-19CompletedNCT04525287
• LLLT Treatment of Lung Inflammation in COVID-19WithdrawnNCT04524715Not applicable
• COVID19-OR (SARS-CoV-2): Observation,Risk & RecoveryCompletedNCT04524520
• Cardiac Dysfunction in Critically Ill Patients With COVID-19CompletedNCT04524234
• Catalysing the Containment of COVID-19TerminatedNCT04523090Phase 2/3
• Rehabilitation After Admission in Intensive Care Unit for COVID-19CompletedNCT04523051
• COVID-19 and HIV PatientsCompletedNCT04523012
• An Exploratory Study of ADR-001 in Patients with Severe Pneumonia Caused by SARS-CoV-2 InfectionCompletedNCT04522986Phase 1
• A Study in Adults to Test the Effects of Low Dose Thimerosal on Symptoms of COVID-19CompletedNCT04522830Phase 2
• CLBS119 for Repair of COVID-19 Induced Pulmonary DamageWithdrawnNCT04522817Phase 1
• Evaluation of the Pharmacokinetics and Pharmacodynamics of Hydroxychloroquine in COVID-19 Intensive Care Unit PatientsTerminatedNCT04522466Phase 3
• ProAdrenomedullin Assessment of Multi-Organ Failure in COvid-19 SepsisCompletedNCT04522310
• Does Quality of Life Decline During the COVID-19 Pandemic and Can we Change Behaviour to Improve Poor Quality of Life?CompletedNCT04522128Not applicable
• A Study to Evaluate the Safety and Immunogenicity of COVID-19 (AdimrSC-2f) VaccineCompletedNCT04522089Phase 1
• Prospective Hospital Registry of Patients With Suspected or Confirmed Coronavirus Infection (COVID-19) and Community-acquired PneumoniaActive, not recruitingNCT04522076
• Measurement of the Efficacy of MORPHINE in the Early Management of Dyspnea in COVID-19 Positive PatientsStatus unknownNCT04522037
• the Investigation Into Beneficial Effects of High-dose Interferon Beta 1-a, Compared to Low-dose Interferon Beta 1-a in Moderate to Severe Covid-19Status unknownNCT04521400Phase 2
• Efficacy of a Nasal Spray Containing Iota-Carrageenan in the Prophylaxis of COVID-19 Disease in Health Personnel Dedicated to Patients Care With COVID-19 DiseaseStatus unknownNCT04521322Phase 4
• SARS-CoV-2 Antibodies Based IVIG Therapy for COVID-19 PatientsCompletedNCT04521309Phase 1/2
• Efficacy and Safety of DWJ1248 in Patients With Mild to Moderate COVID-19 Compared to the PlaceboTerminatedNCT04521296Phase 2/3
• Epidemiological Analysis of Ambulant Patients in a COVID-19 Outpatient ClinicCompletedNCT04521088
• Convalescent Plasma for COVID-19 Patients (CPCP)CompletedNCT04521036Phase 1
• Staff Absenteeism and Delivery of Healthcare Services During the COVID-19 PandemicCompletedNCT04521010
• Antibodies Responses to COVID-19 Infection in Hospitalized PatientsStatus unknownNCT04520880
• Maternal Morbidity and Mortality During the COVID-19 PandemicCompletedNCT04519502
• CSL324 in COVID-19WithdrawnNCT04519424Phase 2
• Transpulmonary Pressure Measurements in Intubated Children With Covid-19 Respiratory FailureWithdrawnNCT04519411Not applicable
• Investigating the Involvement of ACE and Angiotensinogen Genes' Polymorphism Along With Other Thrombophilic Genotypes in Severe Forms of COVID-19 With/Without Thrombotic EventsStatus unknownNCT04519398
• Toclizumam Versus Dexamethasone in Severe Covid-19 CasesCompletedNCT04519385Not applicable
• SARS-CoV-2 /COVID-19 Admission Screening in a University Hospital SettingCompletedNCT04519372
• Study for Quantitative Analysis of the Recovered COVID-19 Patients by 18F-FDG-PET/CTStatus unknownNCT04519255
• Daily Regimen of Tenofovir/Emtricitabine as Prevention for COVID-19 in Health Care Personnel in ColombiaStatus unknownNCT04519125Phase 2/3
• Vitamin D Status and Immune-inflammatory Status in Different UK Populations With COVID-19 InfectionCompletedNCT04519034
• Determination of the Hemoadsorption Impact as Adjunctive Treatment Upon the Support Therapy of COVID-19CompletedNCT04518969Not applicable
• Evolution of COVID-19 in Anticoagulated or Antiaggregated Patients (CORONA Study)CompletedNCT04518735
• Blood Volume Assessment in COVID-19 and Bacterial SepsisCompletedNCT04517695
• Renal Biomarkers in AKI and COVID-19CompletedNCT04517630
• Halodine Nasal Antiseptic in Patients With COVID-19Status unknownNCT04517188Phase 4
• Intramuscular Effect of Polymerized Type I Collagen on the Cytokine Storm in COVID-19 PatientsStatus unknownNCT04517162Phase 1/2
• Impact of Perceived Control on Operational Strain: a Study of COVID-19 Pandemic Caregivers and Military Personnel on Operational MissionsStatus unknownNCT04517136
• Prone Position and Respiratory Outcomes in Non-Intubated COVID-19 PatiEnts The "PRONE" StudyCompletedNCT04517123Not applicable
• Prosocial Behavior Can Safeguard Mental Health and Foster Emotional Well-being During the COVID-19 PandemicCompletedNCT04517006Not applicable
• Convalescent Plasma for COVID-19 PatientsCompletedNCT04516954Early Phase 1

← COVID-19 overview